RENOWNED for its art, history, and above all, churros, Madrid, Spain, saw thousands flock to the city this October for the European Society…

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…

The optimal dressing is still unclear, despite hypospadias being one of the most prevalent surgical operations. Children’s dressing for…

Next-generation sequencing techniques enable rapid detection of mutations present in a patient’s tumour. The next step is to define…

AN INSIGHTFUL session featuring a debate analysed the safety and feasibility of pregnancy amongst survivors of early breast cancer (EBC) at…

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…

Most female carriers of germline BRCA1 mutations develop breast and/or ovarian cancer. However, the penetrance of BRCA1 pathogenic variants…

CURRENT cancer hallmarks, their capabilities, and potential targeted therapies were the focus of the presentation given by Douglas Hanahan…

Lung cancer (LC) remains the top cause of cancer-associated mortality worldwide, with a 10-year overall survival rate of only 5%.1…